Monogram Technologies (MGRM) 17th Annual LD Micro Main Event Conference summary

Technology overview

• Demonstrated a next-generation orthopedic robot with a seven-joint arm for advanced, precise, and autonomous cutting, aiming to revolutionize total joint replacement.

• System enables rapid, safe, and highly accurate cuts, reducing surgical time and improving pre-operative planning.

• Uses CT-based, patient-specific boundaries for safer, more precise procedures compared to legacy systems.

• Focuses on autonomous active cutting, eliminating the need for surgeon-guided cuts and reducing skill dependency.

• Holds over 23 patents protecting the active cutting process and cut sequencing, creating a strong IP moat.

Market dynamics and competitive landscape

• The large joint reconstruction market is valued at $22 billion and is growing, with cementless robotic knees expected to double in three years.

• Current market is dominated by a single incumbent with over 90% share, but their technology is considered outdated and less nimble.

• Robotic solutions currently represent only 12% of the knee market, with the rest being manual, leading to higher error rates and poor outcomes.

• Surgeons and patients are increasingly favoring robotic solutions due to better outcomes and precision.

• The company positions itself as the only viable competitor to the incumbent, leveraging modern technology and a disruptive approach.

Strategic direction and catalysts

• Press-fit (cementless) knees and robotics are expected to become the standard of care, mirroring trends seen in hip replacements.

• Robotics are essential for the precision required in cementless procedures, and adoption is accelerating among new surgeons.

• The company is preparing for major disruption as the market shifts, aiming to capture demand from competitors lacking advanced robotic solutions.

• Holds a strong IP position to defend its market and plans to expand as the standard of care evolves.